Thomas Paul insider trades
Thomas Paul has filed 18 Form 4s with the SEC that we hold, for Axogen, Inc. (AXGN) (Director), NASD (Director), SRGA (Director) and TELA Bio, Inc. (TELA) (Director). Across all of them we count 0 purchases worth $0 and 3 sales worth $1.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($633.6K). The largest single trade was a sale of 21,399 shares of Axogen, Inc. worth $633.6K, dated 2025-12-09. The first filing on our record is dated 2021-07-02 and the latest 2026-06-26.
Axogen, Inc. (AXGN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-12-09 | S, sale reported on Form 4 | 21,399 | $633.6K | 2025-12-10 |
NASD
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-18 | S, sale reported on Form 4 | 663 | $219.3K | 2021-08-19 |
| 2022-11-01 | S, sale reported on Form 4 | 1,000 | $379.4K | 2022-11-03 |
SRGA
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
TELA Bio, Inc. (TELA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1166776) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms